To amend the Controlled Substances Act to provide for the delivery of a controlled substance by a pharmacy to an administering practitioner.
USA115th CongressHR-5202| House
| Updated: 5/9/2018
Ryan A. Costello
Republican Representative
Pennsylvania
Cosponsors (7)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump. The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Forwarded by Subcommittee to Full Committee by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Crime and Law Enforcement
Congressional oversightDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment studies and investigationsHealth personnel
To amend the Controlled Substances Act to provide for the delivery of a controlled substance by a pharmacy to an administering practitioner.
USA115th CongressHR-5202| House
| Updated: 5/9/2018
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump. The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Forwarded by Subcommittee to Full Committee by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Ryan A. Costello
Republican Representative
Pennsylvania
Cosponsors (7)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
Crime and Law Enforcement
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment studies and investigationsHealth personnel